(IN BRIEF) Researchers at the Institute of Cancer Research have demonstrated how immuno-PET imaging can be used to track the immune system’s response to oncolytic virotherapy in real time. Using a modified virus known as RP1 in preclinical models of … Read the full press release →
Posted in Education, Healthcare, Pharma & Biotech, Science, Technology, United Kingdom
Tagged Cancer Immunotherapy, Cancer Research UK, cancer treatment innovation, Chellaram Foundation, Gabriela Kramer Marek, head and neck cancer, ICR London, ICR research demonstrates potential of advanced imaging to guide personalised cancer treatment strategies, immune response, immuno PET, Immuno PET technology offers new insights into timing and effectiveness of cancer immunotherapy combinations, Institute of Cancer Research, Journal of Nuclear Medicine, Julia Höbart, molecular imaging, oncology research, oncolytic virotherapy, Oracle Cancer Trust, PD-L1, RP1 virus
(IN BRIEF) Researchers from The Institute of Cancer Research and Queen’s University Belfast have developed an AI tool to improve the accuracy and consistency of PD-L1 scoring in lung cancer diagnosis. The system uses deep learning to assist pathologists in … Read the full press release →
Posted in Artificial Intelligence (AI), Education, Healthcare, Pharma & Biotech, Science, Technology, United Kingdom
Tagged artificial intelligence, biomarker analysis, digital pathology, immunotherapy, lung cancer, Manuel Salto-Tellez, non-small cell lung carcinoma, NSCLC, oncology, PD-L1, precision medicine, Queen's University Belfast, Researchers advance digital pathology with new AI solution for more reliable lung cancer diagnostics, Scientific Reports, The Institute of Cancer Research, TPS, Tumour Proportion Score
EuropaWire (EW) is the first truly pan-European and leading press release distribution and newswire service for Europe and the European Union working towards consolidating Europe’s voice on the global newswire and media scene. The newswire service comes with advanced submission forms, flexible pricing and PR budgeting, granular targeting, nearly uncapped reach across countries, markets, verticals, industries, audiences, languages, etc., translation and localisation for greater local PR impact, in-depth distribution reporting, metrics and insights including measured PR reach, reads, engagements, impact, etc., no cap on words, images and multimedia to go along with your release, among others. Your press releases will be seen among the releases of Europe’s biggest and most prominent companies, brands and institutions. Here you can learn more about EuropaWire’s mission, achievements, services, etc.
HOW TO GET STARTED?
Load more...
